EUVIMEDEUVIMED entdecken
Crossref

Non-infectious non-anterior uveitis: Pharmacological management

Luis Rodriguez-Rodriguez

Journal of IMIDs · 2021

DOI: 10.24875/jimids.m21000003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of IMIDs, 2021. Verfasst von Luis Rodriguez-Rodriguez.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-infectious non-anterior uveitis (NINA-U) includes a heterogeneous group of sight-threatening conditions.NINA-U can be incapacitating and associated with a profound impact in the quality of life and well-being of the patients.To prevent this catastrophic course, a quick, complete, and maintained suppression of the inflammatory manifestations is required.To achieve this objective, we count with several drugs, including corticosteroids and immunomodulatory drugs (IMDs).Corticosteroids are the cornerstone of NINA-U treatment due to their rapid effect in suppressing inflammation.They can be administered using different routes (periocular, intravitreal, or systemic) depending on the characteristics and location of the disease.Local corticosteroids are able to achieve a high bioavailability within the eye, with minimal systemic dissemination.They are associated with a higher risk of local adverse events (mostly cataracts and elevation of the intraocular pressure).Systemic corticosteroids are usually administered orally, although under certain circumstances, they can be administered intravenously.When corticosteroids alone are not able to control the disease; or when they are associated with serious adverse events; or when the disease is severe, IMDs can be combined with systemic and/or local corticosteroids.Several are used in clinical practice (cyclosporine, methotrexate, azathioprine, mycophenolate mofetil, tacrolimus, cyclophosphamide, and biological agents), based on evidence on their efficacy/effectiveness and safety generated in randomized controlled trials and observational studies, respectively.These drugs are usually used in monotherapy, although several studies have shown that a varying percentage of patients will require changing the IMD or adding a second drug in combination to successfully control the disease.

Zitieren

APA

Rodriguez-Rodriguez, L. (2021). Non-infectious non-anterior uveitis: Pharmacological management. Journal of IMIDs. https://doi.org/10.24875/jimids.m21000003

Vancouver

Rodriguez-Rodriguez L. Non-infectious non-anterior uveitis: Pharmacological management. Journal of IMIDs. 2021. doi:10.24875/jimids.m21000003

BibTeX
@article{RodriguezRodriguez2021,
  author = {Rodriguez-Rodriguez, Luis},
  title = {Non-infectious non-anterior uveitis: Pharmacological management},
  journal = {Journal of IMIDs},
  year = {2021},
  doi = {10.24875/jimids.m21000003}
}
Kostenlos starten →